Bruno Vellas Selected Research

florbetapir

10/2018	Relationship Between Brain Amyloid Deposition and Instrumental Activities of Daily Living in Older Adults: A Longitudinal Study from the Multidomain Alzheimer Prevention Trial.
1/2018	Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease.
1/2018	Cross-sectional associations of plasma vitamin D with cerebral β-amyloid in older adults at risk of dementia.
1/2017	Cross-Sectional and Prospective Associations Between β-Amyloid in the Brain and Chair Rise Performance in Nondementia Older Adults With Spontaneous Memory Complaints.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bruno Vellas Research Topics

Disease

135	Alzheimer Disease (Alzheimer's Disease) 02/2022 - 12/2002
76	Dementia (Dementias) 11/2022 - 04/2003
67	Cognitive Dysfunction 02/2022 - 12/2003
31	Frailty 11/2022 - 06/2013
15	Atrophy 01/2021 - 11/2005
14	Weight Loss (Weight Reduction) 01/2022 - 10/2002
13	Disease Progression 01/2020 - 12/2003
12	Inflammation (Inflammations) 01/2022 - 11/2005
12	Sarcopenia 01/2020 - 08/2003
10	Pneumonia (Pneumonitis) 01/2022 - 09/2013
7	Malnutrition (Nutritional Deficiencies) 10/2016 - 04/2009
7	Osteoporosis 07/2015 - 04/2005
5	Obesity 01/2022 - 08/2006
5	Fatigue 06/2021 - 03/2014
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 11/2008
5	Hypertension (High Blood Pressure) 11/2020 - 11/2012
4	Stroke (Strokes) 01/2022 - 12/2013
4	Infections 11/2020 - 01/2009
4	Pain (Aches) 01/2019 - 01/2007
3	Heart Failure 01/2022 - 12/2013
3	Neuroinflammatory Diseases 01/2022 - 12/2019
3	Atrial Fibrillation 01/2021 - 12/2013
3	Brain Diseases (Brain Disorder) 01/2021 - 10/2012
3	Drug-Related Side Effects and Adverse Reactions 01/2017 - 05/2010
3	Edema (Dropsy) 05/2016 - 01/2012
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2013 - 01/2009
3	Amyloid Plaque 01/2012 - 11/2005
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 01/2021
2	Body Weight (Weight, Body) 01/2022 - 10/2004
2	Neoplasms (Cancer) 01/2022 - 09/2013
2	Chronic Disease (Chronic Diseases) 01/2021 - 11/2012
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2020 - 05/2011
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2019 - 01/2017
2	Disorders of Excessive Somnolence (Hypersomnia) 01/2019 - 01/2017
2	Vitamin D Deficiency 01/2018 - 01/2014

Drug/Important Bio-Agent (IBA)

50	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2007
36	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2012
20	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2011
16	Apolipoproteins E (ApoE)IBA 11/2022 - 01/2010
12	Biological ProductsIBA 10/2021 - 11/2005
12	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2015 - 10/2003
11	Amyloid beta-PeptidesIBA 02/2022 - 09/2007
10	Pharmaceutical PreparationsIBA 01/2022 - 01/2010
10	Vitamin D FDA LinkGeneric 01/2022 - 01/2009
8	ApolipoproteinsIBA 11/2022 - 01/2010
8	LipidsIBA 09/2019 - 01/2014
6	Antipsychotic Agents (Antipsychotics)IBA 06/2019 - 05/2011
6	Indicators and Reagents (Reagents)IBA 01/2018 - 08/2003
5	HomocysteineIBA 10/2021 - 01/2010
5	verubecestatIBA 12/2020 - 01/2018
5	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 11/2020 - 02/2011
5	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2016 - 01/2010
5	Donepezil (Aricept)FDA LinkGeneric 03/2011 - 12/2002
4	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 02/2015
4	CytokinesIBA 01/2022 - 01/2011
4	ProgranulinsIBA 01/2022 - 01/2022
4	C-Reactive ProteinIBA 10/2021 - 01/2019
4	Antidepressive Agents (Antidepressants)IBA 01/2021 - 02/2010
4	Peptides (Polypeptides)IBA 12/2020 - 01/2012
4	florbetapirIBA 10/2018 - 01/2017
4	Memantine (Namenda)FDA Link 11/2011 - 01/2004
3	Pemetrexed (MTA)FDA Link 12/2020 - 01/2008
3	Cholinergic Agents (Cholinergics)IBA 01/2018 - 11/2005
3	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2017 - 01/2014
3	MicronutrientsIBA 01/2015 - 03/2013
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2015 - 01/2010
3	Blood Proteins (Serum Proteins)IBA 11/2014 - 07/2010
3	Ginkgo biloba extract (Rokan)IBA 10/2012 - 04/2003
3	Rivastigmine (Exelon)FDA LinkGeneric 03/2011 - 10/2003
3	Galantamine (Galanthamine)FDA LinkGeneric 03/2011 - 01/2004
3	strontium ranelate (protelos)IBA 02/2011 - 07/2006
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2022 - 01/2022
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2022 - 03/2013
2	CholesterolIBA 01/2022 - 09/2014
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2022 - 01/2017
2	Cholecalciferol (Vitamin D3)FDA Link 01/2022 - 11/2020
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2021 - 01/2017
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 11/2020 - 07/2014
2	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 02/2011
2	lanabecestatIBA 11/2020 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 08/2006
2	EnzymesIBA 01/2020 - 02/2011
2	BenzodiazepinesIBA 12/2019 - 08/2013
2	Cholinergic Antagonists (Anticholinergics)IBA 01/2019 - 05/2010
2	Carrier Proteins (Binding Protein)IBA 01/2019 - 01/2012
2	N-(4-aminophenethyl)spiroperidol (NAPS)IBA 01/2019 - 01/2017
2	AntioxidantsIBA 01/2018 - 03/2013

Therapy/Procedure

35	Activities of Daily Living (ADL) 02/2022 - 06/2003
26	Home Nursing (Nursing, Home) 01/2022 - 02/2007
16	Therapeutics 01/2021 - 12/2003
11	Institutionalization (Institutionalized Persons) 01/2018 - 08/2005
8	Polypharmacy 01/2022 - 06/2009
7	Long-Term Care 12/2018 - 09/2003
6	Patient Care 01/2018 - 01/2013
4	Resistance Training 11/2020 - 05/2011
4	Secondary Prevention 10/2020 - 05/2008
3	Drug Prescriptions 01/2019 - 05/2012
3	Caloric Restriction 01/2016 - 11/2008
2	Precision Medicine 01/2021 - 11/2019
2	Cognitive Training 01/2019 - 05/2017